New Hampshire Resources

This page has information specific to this state, including contact information for federal and state agencies, and some key information about laws and consumer protections.

To find financial assistance resources, please visit CancerFinances.org.

Click here for information about laws specific to New Hampshire.



Federal Fair Employment Agency
Equal Employment Opportunity Commission

Reasonable Accommodations
Job Accommodation Network

Family & Medical Leave Act (FMLA)
U.S. Department of Labor
Wage & Hour Division

State Fair Employment Agency
New Hampshire Commission for Human Rights

Vocational Rehabilitation
New Hampshire Department of Education
603.271.3471 or 1.800.735.2964

More Employment Resources

Unemployment Resources

Unemployment Agency
New Hampshire Employment Security
800.852.3400 or 602.224.3311

Agency: New Hampshire Department of Employment Security

Information and filing available here. Click here to see the current weekly benefit amount and the maximum length of benefits. Initial payments will be made to eligible claimants (including payments for weekly certifications filed while waiting) about 30 days after the first filing. Claimants must maintain a job search log that must be reported when making weekly certifications. A comprehensive guidebook is available here. Frequently asked questions are answered here. Customer service can be reached by contacting the nearest Employment Security office.

Updates related to New Hampshire unemployment benefits and Covid-19

State Clinical Trials Law

The ACA requires that most, non-grandfathered, group health plans provide coverage for the routine costs when participating in clinical trials. Some states have more consumer protections. Click here for more information about clinical trials.

NH Rev. Stat. §415:18-l – The statute applies to grp hospital and medical policies, health service corporations, HMOs, and manages care organizations.  Medicare plans and SCHIP are excluded.  Routine patient care costs are covered for insured participants of a Phase I, II, III, or IV clinical trial for cancer or any other life threatening condition.  Note, coverage for a Phase I or II trial shall be decided on a case-by-case basis in this state.  Coverage is required for reasonable and medically necessary services to administer the drug or device under evaluation in the clinical trial, provided the drug or device is FDA-approved.  This mandate is enforced even whether the FDA has not approved the drug or device for use in treating the participant’s illness or condition.

The clinical trial must be approved by either:  (1) NIH, (2) NIH cooperative group or center, (3) U.S. F.D.A., (4) U.S. Dept. of Defense, (5) U.S. Dept. of Veterans Affairs, or (6) a state IRB.  Second, a superior, non-investigational alternative must not exist, or standard treatment is deemed ineffective.  Third, the facility and personnel providing the experimental treatment must be experienced.  Fourth, data related to the clinical trial must provide a reasonable expectation that the treatment will be at least as effective as the non-investigational alternative. (Updated 1/2011)

More Information